BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26850594)

  • 1. DNA methyltransferase 1, 3a, and 3b expression in hepatitis C associated human hepatocellular carcinoma and their clinicopathological association.
    Siddiqui NN; Ul Haq A; Siddiqui OA; Khan R
    Tumour Biol; 2016 Aug; 37(8):10487-97. PubMed ID: 26850594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methyltransferases 1 and 3b expression in Huh-7 cells expressing HCV core protein of different genotypes.
    Benegiamo G; Vinciguerra M; Mazzoccoli G; Piepoli A; Andriulli A; Pazienza V
    Dig Dis Sci; 2012 Jun; 57(6):1598-603. PubMed ID: 22526584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma.
    Hassouna MM; Naguib M; Radwan EM; Abdel-Samiee M; Estaphan S; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3357-3363. PubMed ID: 33247696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population.
    Maryam M; Idrees M
    J Med Virol; 2018 Sep; 90(9):1516-1523. PubMed ID: 29742286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200b inhibits the proliferation of hepatocellular carcinoma by targeting DNA methyltransferase 3a.
    Li XY; Feng XZ; Tang JZ; Dong K; Wang JF; Meng CC; Wang J; Mo YW; Sun ZW
    Mol Med Rep; 2016 May; 13(5):3929-35. PubMed ID: 26986232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide profiling of DNA methylation reveals preferred sequences of DNMTs in hepatocellular carcinoma cells.
    Fan H; Zhao Z; Cheng Y; Cui H; Qiao F; Wang L; Hu J; Wu H; Song W
    Tumour Biol; 2016 Jan; 37(1):877-85. PubMed ID: 26254611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY; Sohn BH; Yu E; Suh DJ; Chung YH; Lee JH; Surzycki SJ; Lee YI
    Gastroenterology; 2007 Apr; 132(4):1476-94. PubMed ID: 17408664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan.
    Khan A; Tanaka Y; Azam Z; Abbas Z; Kurbanov F; Saleem U; Hamid S; Jafri W; Mizokami M
    J Med Virol; 2009 Jul; 81(7):1189-97. PubMed ID: 19475617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
    Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
    Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.
    Zhu YZ; Zhu R; Shi LG; Mao Y; Zheng GJ; Chen Q; Zhu HG
    Exp Mol Pathol; 2010 Dec; 89(3):268-75. PubMed ID: 20620135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal Nanocurcumin.
    Chamani F; Sadeghizadeh M; Masoumi M; Babashah S
    Asian Pac J Cancer Prev; 2016; 17(S3):219-24. PubMed ID: 27165229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis.
    Mohamed AA; Nada OH; El Desouky MA
    Diagn Pathol; 2012 Aug; 7():103. PubMed ID: 22894766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
    Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic and biological significance of DNA methyltransferase 1 upregulated by growth factors in human hepatocellular carcinoma.
    Fang QL; Yin YR; Xie CR; Zhang S; Zhao WX; Pan C; Wang XM; Yin ZY
    Int J Oncol; 2015 Feb; 46(2):782-90. PubMed ID: 25420499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
    Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
    Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone-modifying genes as biomarkers in hepatocellular carcinoma.
    Hung SY; Lin HH; Yeh KT; Chang JG
    Int J Clin Exp Pathol; 2014; 7(5):2496-507. PubMed ID: 24966962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1.
    Xu H; Li G; Yue Z; Li C
    Mol Med Rep; 2016 Jun; 13(6):5223-9. PubMed ID: 27108614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.